Patient Care
Financial support pilot programme
The diagnosis of Head and Neck cancer can potentially have a large impact on the financial status of a patient and their family, costing families up to £600 more every…
Read MoreThe self-check that could save your life
Dr Elizabeth Marsh, Associate Professor in Cellular and Molecular Biology at the University of Derby,explains how a simple self-screening check could help catch head and neck cancer early. Today (27…
Read MoreCRUK announces 2023 Manifesto for Cancer Research and Care
Cancer Research UK recently presented their “Cancer in the UK: Overview report 2023” and with that launched it’s Manifesto for Cancer Research and Care. It sets out a vision that…
Read MoreThe vital role of specialist Head and Neck Cancer Nurses
At Oracle Cancer Trust we understand the crucial role specialist Head and Neck Cancer Nurses play in the lives of cancer patients. Marking International Nurses Day, we want to celebrate…
Read MoreHow can nutritional therapy support head and neck cancer patients
Written by Maria Rigopoulou, Nutritional Therapist and Nutrigenetics counsellor, member of Nutritionist Resource. As a nutritional therapist and functional medicine practitioner with an interest in cancer, I get many questions…
Read MoreOxford Charity "Heads Up" joins forces with Oracle Cancer Trust
Oracle Cancer Trust is delighted to announce that the charity is joining forces with Oxford-based head and neck cancer research charity Heads Up Friday 9th June 2017 Heads Up was…
Read MoreDietitian Sarah Ballis writes on health and lifestyle for patients
Head and Neck Survivorship: dietary and lifestyle measures to prevent disease Head and neck cancers are still considered to be rare and complex to treat. Like many types of cancer,…
Read More2016 Supporter Research Event
Over 60 supporters joined the team of Oracle researchers and staff to hear about the latest innovations in head and neck cancer projects funded by Oracle Cancer Trust. The event was…
Read MoreImmunotherapy drug for treating HPV+ head and neck cancers hailed as "game-changer"
A new generation of “game-changing” drugs that harness the body’s immune system have been found to extend the lives of head and neck cancer sufferers. The drug, Nivolumab, resulted in…
Read MoreOracle-funded study improves treatment prospects for cancer patients
Read the ICR’s latest blog post about the success of our recent Oracle-funded study into combining radiotherapies with viruses to improve treatment prospects for cancer patients. Oracle-funded scientists at the…
Read More